Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 14 months ago
Share
Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
25 patients around the world
Available in
Argentina, Spain, Brazil, United States, Mexico
GlaxoSmithKline
25
Patients around the world
This study is for people with
Hypereosinophilic Syndrome
Requirements for the patient
To 17 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
SPHERE
Sponsor
GlaxoSmithKline
Study type
Interventional
Conditions
Hypereosinophilic Syndrome
Requirements
To 17 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT04965636
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent